No Data
No Data
Peering Into Legend Biotech's Recent Short Interest
Legend Biotech Down Over 10%, on Pace for Largest Percent Decrease Since July 2022 -- Data Talk
Matthews Emerging Markets Small Companies Fund Boosts Stake in Legend Biotech Corp
HK stocks surge | Genscript Bio (01548) rose nearly 4%, legend biotech's 'Siddarioncel' has been approved for domestic listing.
Genscript Bio (01548) rose nearly 4%, as of press time, up 3.79%, at HK$12.04, with a turnover of HK$39.6598 million.
Beyond The Numbers: 14 Analysts Discuss Legend Biotech Stock
H.C. Wainwright Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $73